Scarica l'app Stockscreener
1.585
10.45%
-0.185
Dopo l'orario di chiusura:
1.70
0.115
+7.26%
Precedente Chiudi:
$1.77
Aprire:
$1.87
Volume 24 ore:
1.71M
Relative Volume:
1.31
Capitalizzazione di mercato:
$257.46M
Reddito:
$400.57M
Utile/perdita netta:
$9.21M
Rapporto P/E:
39.62
EPS:
0.04
Flusso di cassa netto:
$146.36M
1 W Prestazione:
+2.26%
1M Prestazione:
+37.83%
6M Prestazione:
+56.93%
1 anno Prestazione:
-62.35%
Intervallo 1D:
$1.575
$1.94
Intervallo di 1 settimana:
$1.43
$1.94
Portata 52W:
$0.5271
$5.1288
Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile
Nome
Ironwood Pharmaceuticals Inc
Settore
Telefono
617-621-7722
Indirizzo
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Confronta IRWD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRWD
Ironwood Pharmaceuticals Inc
|
1.585 | 287.51M | 400.57M | 9.21M | 146.36M | 0.04 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-15 | Downgrade | Jefferies | Buy → Hold |
| 2025-04-15 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-04-14 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-09-09 | Iniziato | Leerink Partners | Market Perform |
| 2024-08-08 | Downgrade | CapitalOne | Overweight → Equal Weight |
| 2024-01-17 | Iniziato | Craig Hallum | Buy |
| 2023-12-14 | Iniziato | Wells Fargo | Overweight |
| 2023-11-09 | Iniziato | Jefferies | Buy |
| 2023-09-28 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-09-02 | Iniziato | CapitalOne | Overweight |
| 2022-04-22 | Iniziato | Piper Sandler | Overweight |
| 2020-09-30 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-06-17 | Iniziato | Northland Capital | Outperform |
| 2019-07-10 | Ripresa | Credit Suisse | Neutral |
| 2019-03-27 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2019-02-25 | Aggiornamento | H.C. Wainwright | Sell → Neutral |
| 2019-01-24 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2018-11-07 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2018-11-07 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-07-23 | Iniziato | H.C. Wainwright | Sell |
| 2018-05-09 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-01-05 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2017-12-06 | Downgrade | Mizuho | Buy → Neutral |
| 2017-07-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2017-05-03 | Iniziato | Wells Fargo | Outperform |
| 2017-04-07 | Reiterato | Mizuho | Buy |
| 2017-02-22 | Reiterato | Barclays | Equal Weight |
| 2016-11-04 | Reiterato | Mizuho | Buy |
| 2016-10-24 | Reiterato | Wedbush | Neutral |
| 2016-10-10 | Reiterato | Mizuho | Buy |
| 2016-09-27 | Reiterato | WallachBeth | Hold |
Mostra tutto
Ironwood Pharmaceuticals Inc Borsa (IRWD) Ultime notizie
Ironwood Pharma Board Member Resigns for New Role - TipRanks
Ironwood Pharmaceuticals director Andrew Dreyfus to resign effective November 1 - Investing.com
Can technical indicators confirm Ironwood Pharmaceuticals Inc.’s reversal2025 Trade Ideas & Expert Verified Stock Movement Alerts - newser.com
Applying Wyckoff theory to Ironwood Pharmaceuticals Inc. stock2025 Institutional Moves & Real-Time Volume Analysis - newser.com
Weiss Ratings Reiterates Sell (E+) Rating for Ironwood Pharmaceuticals (NASDAQ:IRWD) - MarketBeat
Published on: 2025-10-09 01:18:56 - newser.com
Ironwood Pharmaceuticals Inc. stock daily chart insights2025 Technical Patterns & AI Driven Price Predictions - newser.com
Ironwood Pharmaceuticals (NASDAQ:IRWD) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
How risky is Ironwood Pharmaceuticals Inc. stock nowJuly 2025 Drop Watch & Community Shared Stock Ideas - newser.com
Reversal indicators forming on Ironwood Pharmaceuticals Inc. stockWeekly Trend Summary & Real-Time Buy Zone Alerts - newser.com
What MACD and RSI say about Ironwood Pharmaceuticals Inc.2025 Investor Takeaways & AI Enhanced Trading Signals - newser.com
Can Ironwood Pharmaceuticals Inc. (I76) stock retain market dominanceFed Meeting & Capital Efficient Trading Techniques - newser.com
Can Ironwood Pharmaceuticals Inc. hit a new high this monthJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Visualizing Ironwood Pharmaceuticals Inc. stock with heatmapsMarket Growth Report & Daily Market Momentum Tracking - newser.com
Strategies to average down on Ironwood Pharmaceuticals Inc.2025 Key Lessons & Technical Pattern Based Signals - newser.com
Will Ironwood Pharmaceuticals Inc. price bounce be sustainableShare Buyback & Free Weekly Watchlist of Top Performers - newser.com
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Can momentum traders help lift Ironwood Pharmaceuticals Inc.July 2025 Rallies & High Yield Stock Recommendations - newser.com
Published on: 2025-10-03 03:28:42 - newser.com
Published on: 2025-10-01 06:27:53 - newser.com
IRWD's Q4 Earnings and Revenues Fall Shy of Estimates, Stock Down - MSN
Ironwood focuses on apraglutide amid workforce cuts - MSN
Is Ironwood Pharmaceuticals Inc. stock reversal real or fakeQuarterly Trade Report & Community Verified Swing Trade Signals - newser.com
Top chart patterns to watch in Ironwood Pharmaceuticals Inc.Recession Risk & Real-Time Market Trend Scan - newser.com
Regression analysis insights on Ironwood Pharmaceuticals Inc. performanceInsider Selling & High Yield Stock Recommendations - newser.com
Is Ironwood Pharmaceuticals Inc I76 a good long term investmentBearish Engulfing Patterns & High Yield Trading Alerts - earlytimes.in
Is Ironwood Pharmaceuticals Inc a good long term investmentBearish Engulfing Patterns & Exceptional Capital Trading - earlytimes.in
What drives Ironwood Pharmaceuticals Inc stock priceSector Performance Drivers & Smarter Trades Backed by Machine Learning - earlytimes.in
Ironwood Pharmaceuticals Inc Azioni (IRWD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ironwood Pharmaceuticals Inc Azioni (IRWD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| John Minardo | Chief Legal Officer |
Aug 11 '25 |
Sale |
0.84 |
7,754 |
6,513 |
400,378 |
| Martini Gregory S. | Chief Financial Officer |
Aug 11 '25 |
Sale |
0.84 |
1,265 |
1,063 |
182,545 |
| Silver Ronald | Principal Accounting Officer |
Aug 11 '25 |
Sale |
0.84 |
2,846 |
2,391 |
276,809 |
1.54%
1.20%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):